Follow
Yuqing Zhang
Yuqing Zhang
Dana-Farber Cancer Institute
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
H Huang, Z Wang, Y Zhang, RN Pradhan, D Ganguly, R Chandra, ...
Cancer Cell 40 (6), 656-673. e7, 2022
2142022
Targeting TGF βR2‐mutant tumors exposes vulnerabilities to stromal TGF β blockade in pancreatic cancer
H Huang, Y Zhang, V Gallegos, N Sorrelle, MM Zaid, J Toombs, W Du, ...
EMBO molecular medicine 11 (11), e10515, 2019
642019
Improved multiplex immunohistochemistry for immune microenvironment evaluation of mouse formalin-fixed, paraffin-embedded tissues
N Sorrelle, D Ganguly, ATA Dominguez, Y Zhang, H Huang, LN Dahal, ...
The Journal of Immunology 202 (1), 292-299, 2019
492019
Direct and indirect regulation of the tumor immune microenvironment by VEGF
Y Zhang, RA Brekken
Journal of leukocyte biology 111 (6), 1269-1286, 2022
402022
The characteristics of naive-like T cells in tumor-infiltrating lymphocytes from human lung cancer
SY Sheng, Y Gu, CG Lu, YY Tang, JY Zou, YQ Zhang, RF Wang, H Hong
Journal of Immunotherapy 40 (1), 1-10, 2017
242017
VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment
Y Zhang, H Huang, M Coleman, A Ziemys, P Gopal, SM Kazmi, ...
JCI insight 6 (23), 2021
232021
Perspectives on hypoxia signaling in tumor stroma
Y Zhang, M Coleman, RA Brekken
Cancers 13 (12), 3070, 2021
192021
Cyclooxygenase-2 inhibition potentiates the efficacy of vascular endothelial growth factor blockade and promotes an immune stimulatory microenvironment in preclinical models of …
Y Zhang, A Kirane, H Huang, NB Sorrelle, FJ Burrows, MT Dellinger, ...
Molecular Cancer Research 17 (2), 348-355, 2019
182019
AXL is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
W Du, NZ Phinney, H Huang, Z Wang, J Westcott, JE Toombs, Y Zhang, ...
Molecular Cancer Research 19 (8), 1412-1421, 2021
172021
Effects of glycogen synthase kinase-3β inhibitor TWS119 on proliferation and cytokine production of TILs from human lung cancer
YY Tang, SY Sheng, CG Lu, YQ Zhang, JY Zou, YY Lei, Y Gu, H Hong
Journal of Immunotherapy 41 (7), 319-328, 2018
162018
AXL inhibitor TP-0903 reduces metastasis and therapy resistance in pancreatic cancer
Y Zhang, EN Arner, A Rizvi, JE Toombs, H Huang, SL Warner, JM Foulks, ...
Molecular cancer therapeutics 21 (1), 38-47, 2022
112022
Are TEMs canceled? Questioning the functional relevance of tie2-expressing macrophages
Y Zhang, RA Brekken
Cancer research 82 (7), 1172-1173, 2022
22022
Selective inhibition of VEGF binding to VEGFR2 promotes an immune stimulatory microenvironment in murine models of breast cancer.
Y Zhang, H Huang, N Sorrelle, R Brekken
CANCER IMMUNOLOGY RESEARCH 9 (2), 2021
2021
Abstract PR011: Selective inhibition of VEGF binding to VEGFR2 promotes an immune stimulatory microenvironment in murine models of breast cancer
Y Zhang, H Huang, N Sorrelle, R Brekken
Cancer Immunology Research 9 (2_Supplement), PR011-PR011, 2021
2021
Immune toxicity and flow cytometry of circulating blood cells in cancer patients receiving immune therapy.
SA Khan, N Sorrelle, RA Brekken, R Lu, MS von Itzstein, D Xie, D Hsieh, ...
Journal of Clinical Oncology 38 (15_suppl), e15126-e15126, 2020
2020
Abstract C092: Axl inhibitor TP-0903 augments chemo-and immunotherapy efficacy in pancreatic cancer
Y Zhang, EN Arner, JE Toombs, JM Foulks, SL Warner, RA Brekken
Molecular Cancer Therapeutics 18 (12_Supplement), C092-C092, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–16